Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Darja Beyer

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecular Pharmaceutics|May 6, 2025
Design and Preclinical Evaluation of Novel uPAR-Targeting Radiopeptides Modified with an Albumin-Binding EntityDarja Beyer, Christian Vaccarin, Jerome V Schmid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 27, 2025
Optimizing uPAR-targeting radiopeptides for improved tissue distribution: progress towards radionuclide therapyChristian Vaccarin, Darja Beyer, Jerome V Schmid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 27, 2024
Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2Jinling Wang, Darja Beyer, Christian Vaccarin, et al.
Journal of Structural Biology: X|May 7, 2026
Development and structure-guided characterization of a novel ACE2-binding macrocyclic peptideRoger M Benoit, Jinling Wang, Darja Beyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 6, 2025
Development of lisinopril radioconjugates for nuclear imaging of the angiotensin converting enzymeChristian Vaccarin, Darja Beyer, Anzhelika Moiseeva, et al.
EJNMMI Research|April 19, 2023
A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptidesDarja Beyer, Christian Vaccarin, Xavier Deupi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecular Pharmaceutics|May 6, 2025
Design and Preclinical Evaluation of Novel uPAR-Targeting Radiopeptides Modified with an Albumin-Binding EntityDarja Beyer, Christian Vaccarin, Jerome V Schmid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 27, 2025
Optimizing uPAR-targeting radiopeptides for improved tissue distribution: progress towards radionuclide therapyChristian Vaccarin, Darja Beyer, Jerome V Schmid, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 27, 2024
Development of radiofluorinated MLN-4760 derivatives for PET imaging of the SARS-CoV-2 entry receptor ACE2Jinling Wang, Darja Beyer, Christian Vaccarin, et al.
Journal of Structural Biology: X|May 7, 2026
Development and structure-guided characterization of a novel ACE2-binding macrocyclic peptideRoger M Benoit, Jinling Wang, Darja Beyer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 6, 2025
Development of lisinopril radioconjugates for nuclear imaging of the angiotensin converting enzymeChristian Vaccarin, Darja Beyer, Anzhelika Moiseeva, et al.
EJNMMI Research|April 19, 2023
A tool for nuclear imaging of the SARS-CoV-2 entry receptor: molecular model and preclinical development of ACE2-selective radiopeptidesDarja Beyer, Christian Vaccarin, Xavier Deupi, et al.
Pageof 1